Literature DB >> 32472661

Global burden of noncommunicable diseases attributable to high fasting plasma glucose.

Lingxia Ye1, Jingya Xu1, Tianyue Zhang1, Xiling Lin1, Xiaowen Pan1, Wenheng Zeng1, Yuezhong Ren1, Pengfei Shan1.   

Abstract

BACKGROUND: Hyperglycemia is a major public health concern. An understanding of the latest trends of the global burden of noncommunicable diseases (NCDs) by high fasting plasma glucose (HFPG) is critical for determining research priorities and planning health policy.
METHODS: This is a comparative burden-of-disease study. We obtained global, regional, and national data on deaths and disability-adjusted life years (DALYs) of NCDs attributable to HFPG from the Global Burden of Disease Study 2017, performed a secondary analysis of deaths and DALYs by time, age, gender, location, and specific causes, and analyzed their associations.
RESULTS: In 2017, 6.39 million deaths and 166.36 million DALYs from NCDs were attributable to HFPG, accounting for 15.6% and 10.7% of all deaths and DALYs, respectively. The burden's rate decreased with time, increased with age and was significantly higher in males. A negative association was found between the sociodemographic index (SDI) and disease burden, and a positive association was found between SDI and male superiority by gender difference and gender ratio.
CONCLUSIONS: The burden of NCDs attributable to HFPG has increased significantly since 1990 and varied widely across regions. Greater efforts are needed to prevent and control hyperglycemia, especially in less developed countries and among males.
© 2020 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  fasting plasma glucose; global burden of disease; hyperglycemia; noncommunicable diseases; 全球疾病负担; 空腹血糖; 非传染性疾病; 高血糖

Mesh:

Substances:

Year:  2020        PMID: 32472661     DOI: 10.1111/1753-0407.13072

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  4 in total

1.  Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.

Authors:  Karthikeyan Subbarayan; Kamatchi Ulagappan; Claudia Wickenhauser; Michael Bachmann; Barbara Seliger
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

2.  Health Effects of Metabolic Risks in the United States From 1990 to 2019.

Authors:  Ruifang Chen; Saeid Safiri; Masoud Behzadifar; Jude Dzevela Kong; Mohamed Sami Zguira; Nicola Luigi Bragazzi; Wen Zhong; Weiru Zhang
Journal:  Front Public Health       Date:  2022-01-31

3.  Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.

Authors:  Saeid Safiri; Seyed Aria Nejadghaderi; Nahid Karamzad; Jay S Kaufman; Kristin Carson-Chahhoud; Nicola Luigi Bragazzi; Mark J M Sullman; Mohammad Reza Beyranvand; Mohammad Ali Mansournia; Amir Almasi-Hashiani; Gary S Collins; Ali-Asghar Kolahi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

4.  Global, regional, and national burden of blindness and vision loss due to common eye diseases along with its attributable risk factors from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.

Authors:  Xiaorong Yang; Hui Chen; Tongchao Zhang; Xiaolin Yin; Jinyu Man; Qiufeng He; Ming Lu
Journal:  Aging (Albany NY)       Date:  2021-08-09       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.